These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5299490)

  • 1. Study of the effect of N-methyl carbamate on the electroencephalogram in cerebral arteriosclerosis.
    Mori A; Ishikawa Y; Mukoyama K
    Jpn Heart J; 1967 May; 8(3):234-41. PubMed ID: 5299490
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pyridinolcarbamate treatment of ischemic heart disease].
    Kuz'ko NV
    Vrach Delo; 1976 Jan; (1):27-30. PubMed ID: 1246850
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of the effectiveness of anginin and stugeron treatment of cerebral arteriosclerosis].
    Sobczyk W; Kruszewska J; Szymchel J
    Neurol Neurochir Pol; 1980; 14(2):183-9. PubMed ID: 6993976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of papaverine on systemic and cerebral hemodynamics in atherosclerosis complicated by chronic cerebral circulatory insufficiency].
    Komorovskaia IaM; Nechaĭ EE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(9):1308-12. PubMed ID: 6506974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Results of Paveron 75 therapy in negatively selected patients with cerebral function disorders].
    Klaus P; Wiethaup H
    Med Welt; 1973 Sep; 24(37):1413-4. PubMed ID: 4587961
    [No Abstract]   [Full Text] [Related]  

  • 6. [Regional cerebral blood flow and its regulation in the initial stage of cerebral arteriosclerosis].
    Man'kovskiĭ NB; Mints AIa; Lizogub VG; Kim B
    Klin Med (Mosk); 1979 Sep; 57(9):35-9. PubMed ID: 40063
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of theophyllinyl 7- -n propane sulfonate of papaverine in rehabilitation and functional readaptation].
    Blanc A; Perset P
    Therapeutique; 1971 Apr; 47(4):391-3. PubMed ID: 5564052
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical and rheoencephalographical evaluation of prodectin in the treatment of cerebral arteriosclerosis].
    Wysocka-Bakowska MM
    Neurol Neurochir Pol; 1981; 15(4):431-36. PubMed ID: 7035991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An ergot alkaloid preparation (Hydergine) versus papaverine in treating common complaints of the aged: double-blind study.
    Bazo AJ
    J Am Geriatr Soc; 1973 Feb; 21(2):63-71. PubMed ID: 4631704
    [No Abstract]   [Full Text] [Related]  

  • 10. [Results of hypotensive treatment in a hospital environment].
    Pavesi V; Campus G
    Minerva Med; 1968 May; 59(40):2345-50. PubMed ID: 5653333
    [No Abstract]   [Full Text] [Related]  

  • 11. [Diagnostic and therapeutic difficulties in cerebral atherosclerosis (author's transl)].
    Zdichynec B
    Cesk Psychiatr; 1974 Feb; 70(1):42-6. PubMed ID: 4452124
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of pyridinocarbamate in chronic cerebral arteriosclerosis].
    de Oliveira JM
    Hospital (Rio J); 1970 Feb; 77(2):441-50. PubMed ID: 4393836
    [No Abstract]   [Full Text] [Related]  

  • 13. Papaverin in the treatment of geriatric patients.
    Bambasová E; Bílková J; Budínská K
    Act Nerv Super (Praha); 1974 Aug; 16(3):191-2. PubMed ID: 4609360
    [No Abstract]   [Full Text] [Related]  

  • 14. [Rheographic study of the activity of some vasoactive drugs on peripheral arterial circulation].
    Capitanucci P; Martinelli M; De Gregorio M
    Minerva Cardioangiol; 1968 Nov; 16(11):1074-82. PubMed ID: 5707452
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical study of a new vasodilating agent (Dilydrin) in cerebral vascular disorders and strokes].
    Probst G; Keiser G
    Praxis; 1969 Dec; 58(50):1653-8. PubMed ID: 4905566
    [No Abstract]   [Full Text] [Related]  

  • 16. Antagonism of levodopa by papaverine.
    Duvoisin RC
    JAMA; 1975 Feb; 231(8):845-6. PubMed ID: 1172755
    [No Abstract]   [Full Text] [Related]  

  • 17. [The use of high doses of papaverine in cerebral arteriosclerotic vascular disease].
    Bianchi G
    Clin Ter; 1970 Mar; 52(5):461-70. PubMed ID: 5421987
    [No Abstract]   [Full Text] [Related]  

  • 18. [Characteristics of the action of gemiton, adelfan and dopegit on cerebral circulation in arterial hypertension].
    Eninia GI; Smeltere ES; Godlevska MA; Uzulinia IP
    Klin Med (Mosk); 1984 Mar; 62(3):100-3. PubMed ID: 6716915
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapeutic efficacy of pyridinolcarbamate (Anginin) in patients with combined cerebral and peripheral arteriosclerosis].
    Majkowski J; Lysakowska-Sernicka K; Gajewska A; Bilińska-Nigot B; Ostrowski K; Semenicki K
    Neurol Neurochir Pol; 1978; 12(4):387-96. PubMed ID: 714218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sturgeron treatment effectiveness in early cerebral arteriosclerosis].
    Belonog RP; Karaban' IN
    Vrach Delo; 1980 Sep; (9):67-9. PubMed ID: 7423956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.